RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
  Bladder
  Blood
  Bone Cancer
  Brain
  Breast Cancer
  Carcinogens
  Cervical Cancer
  Colon
  Endometrial
  Esophageal
  Gastric Cancer
  Liver Cancer
  Lung
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Skin
  Testicular Cancer
  Therapy
  Thyroid
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Breast Cancer Channel

subscribe to Breast Cancer newsletter
Latest Research : Cancer : Breast Cancer

   EMAIL   |   PRINT
Cancer Screening Useful in Breast Reduction Surgery Patients

Sep 28, 2005 - 1:07:00 PM
“We are in a time in medicine when cost is an important factor. Pressure from insurance companies and general administrators often force physicians to consider the cost of care when treating a patient”

 
[RxPG] Twelve percent of breast reduction patients may have abnormal pathologies placing them at an increased risk of developing breast cancer, according to a study presented today at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2005 conference in Chicago. In addition, the authors found it more cost effective to screen breast reduction patients of all ages, not just those over 40, the age when routine screening mammography is recommended.

Plastic surgeons who perform breast reductions routinely have the removed tissue tested for abnormalities. While the screening of each patient may detect breast cancer early, it also escalates the overall cost.

“We are in a time in medicine when cost is an important factor. Pressure from insurance companies and general administrators often force physicians to consider the cost of care when treating a patient,” said Kristin Stueber, MD, ASPS Member Surgeon and co-author of the study. “However, detecting breast cancer as early as possible reduces treatment costs and saves lives. In the end, we found that although it may cost more up-front to screen each breast reduction patient for cancer, we saved money and helped patients to get treatment sooner.”

In the study, 12 percent of the 300 patients tested, ranging from 14 to 73 years old, had abnormal pathology reports indicating either a premalignant lesion or a lesion that puts the patient at an increased risk of developing breast cancer. Of those with an abnormal outcome, 28 percent were deemed moderate or high risk, placing them at a significantly higher threat than the general population for developing breast cancer. Two of the 10 high-risk patients were less than 40 years old. Any patient with an abnormal test was referred to a comprehensive breast center to watch for indications of breast cancer.

Based on the study of 300 patients where pathologic examination of each patient’s breast tissue was $381.72, there could have been a savings of $81,688 by only testing women above the age of 40, who equaled less than 29 percent of the patients. However, selective testing would have missed two potential cases of breast cancer.

“If we were to limit our pathologic examination of breast tissue to breast reduction patients older than 40, we would fail to identify 20 percent of moderate to high risk pathology, which is simply not an acceptable risk,” said Dr. Stueber. “Besides the potential cost savings in testing, the cost for treating a cancer patient down the road is certainly more than any savings we could produce in the short term.”

More than 105,500 women had breast reduction surgery in 2004, according to ASPS statistics. Applying the findings of this study to last year’s numbers, if the medical community only tested women above the age of 40, it would have missed 633 cases of moderate to high risk breast cancer.

Breast cancer is 90 percent curable when discovered early. An estimated 211,240 new invasive cases of breast cancer are expected to occur in 2005 among women in the United States, according to the American Cancer Society. This year, more than 40,000 women are expected to die from the disease.



Publication: This study was pesented on Sunday, Sept. 25, McCormick Place Lakeside Center, Chicago.
On the web: www.plasticsurgery.org 

Advertise in this space for $10 per month. Contact us today.


Related Breast Cancer News
Blood test predicts breast cancer recurrence
Interferon-stimulated gene 15 (ISG15), a ubiquitin like protein, is a new therapeutic target for breast cancer
Smoking may have an association with breast cancer in women
Vitamins and calcium supplements appear to reduce the risk of breast cancer
Acupuncture has added benefits in breast cancer patients
Study finds higher risk of cancer recurrence in women with dense breasts
Physical activity after menopause reduces breast cancer
Genes responsible for susceptibility to breast cancer metastasis can be inherited
Oestrogen therapy of benefit in some women with metastatic cancer
Awry protein linked to breast cancer

Subscribe to Breast Cancer Newsletter

Enter your email address:


 Additional information about the news article
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. With more than 5,800 Member Surgeons, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)